FORESITE CAPITAL MANAGEMENT IV, LLC – Aclaris Therapeutics, Inc. Transaction History
FORESITE CAPITAL MANAGEMENT IV, LLC portfolio value:
$44.19M
portfolio value
FORESITE CAPITAL MANAGEMENT IV, LLC quarter portfolio value change:
+12.75%
quarter
Aclaris Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 4.99M | $15.74 | 2.80M | |
| Q2 2022 | share | Decrease | -3.14% | -91K shares | -10.77M | $13.96 | 2.80M |
| Q1 2022 | share | Decrease | -14.71% | -500K shares | 557K | $17.24 | 2.89M |
| Q4 2021 | share | 0.00% | 0 shares | -11.76M | $14.33 | 3.39M | |
| Q3 2021 | share | 0.00% | 0 shares | 1.49M | $18 | 3.39M | |
| Q2 2021 | share | 0.00% | 0 shares | -25.96M | $17.56 | 3.39M | |
| Q1 2021 | share | Increase | +257.27% | 2.44M shares | 79.50M | $25.2 | 3.39M |
| Q4 2020 | share | Increase | +556.70% | 806.51K shares | 5.78M | $6.47 | 951.38K |
| Q3 2020 | share | Increase | 0.00% | 144.87K shares | 372K | $2.57 | 144.87K |
| Q1 2019 | share | Decrease | -100.00% | -748.13K shares | -5.52M | $5.99 | 0 |
| Q4 2018 | share | Increase | +41.28% | 218.58K shares | -2.16M | $7.39 | 748.13K |
| Q3 2018 | share | 0.00% | 0 shares | -2.88M | $14.52 | 529.55K | |
| Q2 2018 | share | Increase | +23.28% | 100K shares | 3.04M | $19.97 | 529.55K |
| Q1 2018 | share | Increase | +70.50% | 177.61K shares | 1.31M | $17.52 | 429.55K |
| Q4 2017 | share | Increase | 0.00% | 251.93K shares | 6.21M | $24.66 | 251.93K |